Johnson & Johnson (JNJ) sa\u011fl\u0131k sekt\u00f6r\u00fcnde faaliyet g\u00f6sterir; Innovative Medicine (yenilik\u00e7i ila\u00e7) ve MedTech (t\u0131bbi teknoloji\/cihaz) olmak \u00fczere iki ana b\u00f6l\u00fcm\u00fc vard\u0131r ve NYSE\u2019de (New York Borsas\u0131) \u201cJNJ\u201d koduyla i\u015flem g\u00f6r\u00fcr. Tahmin, Ocak 2025\u2019te g\u00f6r\u00fclen dip seviyeden sonra y\u00fckseli\u015f (pozitif) bir hareket dizisi bekliyor.<\/p>\n
G\u00f6r\u00fc\u015fe g\u00f6re fiyat, ((4)) dalgas\u0131 i\u00e7inde a\u015fa\u011f\u0131 y\u00f6nl\u00fc \u201c\u00e7ift d\u00fczeltme\u201d (iki a\u015famal\u0131 d\u00fczeltme yap\u0131s\u0131) ya\u015f\u0131yor. Destek (fiyat\u0131n d\u00fc\u015f\u00fc\u015fte tutunmas\u0131n\u0131n beklendi\u011fi b\u00f6lge) $227,80\u2013$215,82 aral\u0131\u011f\u0131nda g\u00f6r\u00fcl\u00fcyor; al\u0131c\u0131lar\u0131n bu b\u00f6lgeye en az \u201c\u00fc\u00e7 sal\u0131n\u0131ml\u0131\u201d (en az \u00fc\u00e7 par\u00e7a halinde) bir tepki y\u00fckseli\u015fi i\u00e7in girmesi bekleniyor.<\/p>\n
Haftal\u0131k grafikte, (I) dalgas\u0131 Nisan 2022\u2019de $186,69\u2019da bitti ve (II) dalgas\u0131 Ocak 2025\u2019te $140,68\u2019de tamamland\u0131. (II) i\u00e7inde w $150,11\u2019de, x $175,97\u2019de ve y $140,68\u2019de bitti; bu yap\u0131 \u201cdalgal\u0131 \u00e7ift \u00fc\u00e7\u201d (iki kez tekrarlayan, par\u00e7al\u0131\/karars\u0131z d\u00fczeltme) olarak tan\u0131mlan\u0131yor.<\/p>\n
Nisan 2025\u2019teki dipten itibaren, ((1)) $169,99\u2019da, ((2)) $141,50\u2019de ve ((3)) $251,71\u2019de bitti. ((3)) i\u00e7inde (1) $159,44\u2019te, (2) $146,12\u2019de, (3) $215,19\u2019da, (4) $200,91\u2019de ve (5) $251,71\u2019de tamamland\u0131.<\/p>\n
$251,71\u2019in alt\u0131nda, ((4)) i\u00e7inde \u201cyedi sal\u0131n\u0131ml\u0131\u201d (yedi par\u00e7al\u0131) bir geri \u00e7ekilme bekleniyor. ((4)) i\u00e7inde (W) $232,24\u2019te, (X) $247,21\u2019de bitti; (Y) ise $227,80\u2013$215,82 band\u0131na do\u011fru daha a\u015fa\u011f\u0131da \u00f6ng\u00f6r\u00fcl\u00fcyor. Sonraki hedef $259\u2019un \u00fczeri.<\/p>\n
Bu metin Johnson & Johnson\u2019da Ocak 2025\u2019te ba\u015flayan g\u00fc\u00e7l\u00fc bir y\u00fckseli\u015f trendi (ana y\u00f6n) g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc ve hissenin \u015fu anda ge\u00e7ici bir geri \u00e7ekilme i\u00e7inde oldu\u011funu savunuyor. Bu geri \u00e7ekilme \u201csa\u011fl\u0131kl\u0131 d\u00fczeltme\u201d olarak de\u011ferlendiriliyor ve fiyat $227,80\u2013$215,82 ana destek alan\u0131na yakla\u015f\u0131rken al\u0131m f\u0131rsat\u0131 olarak g\u00f6r\u00fcl\u00fcyor.<\/p>\n
Bu y\u00fckseli\u015f beklentisi, \u015firketin son bir y\u0131ldaki g\u00fc\u00e7l\u00fc performans\u0131na, \u00f6zellikle 2025 4. \u00e7eyrek finansal sonu\u00e7lar\u0131na dayan\u0131yor. Rapora g\u00f6re gelirler ge\u00e7en y\u0131l\u0131n ayn\u0131 d\u00f6nemine g\u00f6re %12 artt\u0131; art\u0131\u015f\u0131n ana kayna\u011f\u0131 MedTech b\u00f6l\u00fcm\u00fcd\u00fcr. Bu temel veriler, teknik g\u00f6r\u00fcn\u00fcmde ana trendin yukar\u0131 oldu\u011funa dair g\u00f6r\u00fc\u015f\u00fc destekliyor.<\/p>\n
Ge\u00e7mi\u015fe bak\u0131ld\u0131\u011f\u0131nda hisse, Nisan 2025 dibine yak\u0131n $141,50\u2019den $251,71 tepesine yakla\u015f\u0131k %78 y\u00fckseldi. Bu kadar g\u00fc\u00e7l\u00fc bir y\u00fckseli\u015ften sonra d\u00fczeltme normal kabul edilir. Mevcut d\u00fc\u015f\u00fc\u015f, ((4)) dalgas\u0131 geri \u00e7ekilmesi olarak yorumlan\u0131yor ve bir sonraki y\u00fckseli\u015f aya\u011f\u0131nda $259 \u00fczeri fiyatlara zemin haz\u0131rlad\u0131\u011f\u0131 d\u00fc\u015f\u00fcn\u00fcl\u00fcyor.<\/p>\n","protected":false},"excerpt":{"rendered":"
JNJ\u2019de g\u00f6zler kritik destek band\u0131nda: Ocak 2025 dip sonras\u0131 y\u00fckseli\u015f trendi s\u00fcr\u00fcyor. Hisse ((4)) dalgas\u0131nda 227,80\u2013215,82\u2019ye d\u00fczeltip tepki ar\u0131yor; hedef 259+; MedTech gelir art\u0131\u015f\u0131 (%12) destekliyor.<\/p>\n","protected":false},"author":87,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[71],"tags":[],"class_list":["post-45134","post","type-post","status-publish","format-standard","hentry","category-live-updates"],"acf":{"acf_article_selection_author":null},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/posts\/45134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/users\/87"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/comments?post=45134"}],"version-history":[{"count":0,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/posts\/45134\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/media?parent=45134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/categories?post=45134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/tags?post=45134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}